Search Results 1391-1400 of 19168 for Neutrophil

1. A Study to Evaluate the Safety and Effectiveness of Axicabtagene Ciloleucel in Combination with Rituximab in Participants With Refractory Large B-Cell Lymphoma (ZUMA-14) - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1,000/μL. Growth factor 7 days prior to screening is not allowed to meet ANC eligibility criteria. Platelet count ...

2. Publications - Andre M. Oliveira, M.D., Ph.D. - Mayo Clinic

   Oncolytic measles virotherapy encoding the neutrophil-activating protein is effective in synovial sarcoma. Molecular Therapy Oncology. 2025; 33 (4):201062

3. Immune Response to Antigens - Clinical Trials

   The purpose of this study is to sequence patient germline and tumor samples, and nominate top neoantigen candidates using an in-house developed bioinformatics ...

4. Study to Compare the Safety and Effectiveness of Treatment Combinations in Patients with Recurrent Ovarian Cancer - Mayo Clinic

   Absolute neutrophil count ≥1,500/μL, without growth factor support (granulocyte colonystimulating factor or granulocyte-macrophage colony-stimulating ...

5. A Study to Evaluate Tazemetostat and Pembrolizumab to Treat Advanced Urothelial Carcinoma - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/mcL (performed within 14 days prior to registration). Platelets ≥ 100 000/mcL (performed within 14 days prior to ...

6. Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/mm3 (≥ 1.5 GI/L) without granulocyte colony-stimulating factor support within 2 weeks before screening laboratory ...

7. A Study to Evaluate HH2853 in Patients with Relapsed/Refractory Non-Hodgkin's Lymphomas or Advanced Solid Tumors - Mayo Clinic

   Absolute Neutrophil Count (ANC) ≥ 1.0 x 10^9/L 7. Adequate coagulation function: International normalized ratio (INR) <1.3 (or <3.0 on anticoagulants)

8. Determining Lipid Content in Stool After Alpha-cyclodextrin - Mayo Clinic

   Adequate bone marrow function: white blood cells (WBCs) ≥ 3,000/mm^3, absolute neutrophil count (ANC) ≥ 1,500/mm^3, hemoglobin ≥ 9 gram/deciLiter, and ...

9. A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma - Mayo Clinic

   Absolute neutrophil count ≥ 1,000/uL (unsupported) within 7 days prior to enrollment. Platelets ≥ 100,000/uL (unsupported) within 7 days prior to ...

10. A Study of Pembrolizumab Alone or Combined with CC-486 for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer - Mayo Clinic

    Adequate organ function within 7 days prior to enrollment, as defined by the following criteria. Absolute neutrophils count (ANC) ≥ 1.5 x 10E9/L; Platelets ...